Last reviewed · How we verify

NCT03993795

CSD190103: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products

Completed NA Last updated 25 October 2019
What this trial tests

NA trial testing A19010-W in Tobacco Use in 63 participants. Completed in 20 September 2019.

Timeline
8 July 2019
Primary endpoint
20 September 2019
20 September 2019

Quick facts

Lead sponsorRAI Services Company
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Enrollment63
Start date8 July 2019
Primary completion20 September 2019
Estimated completion20 September 2019
Sites6 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

RAI Services Company

Who can join

Adults 21 to 60, any sex, with Tobacco Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare plasma nicotine uptake in adult snus consumers after using investigational snus products (A19010-W and B19010-F).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Tobacco Use

Currently open trials in the same condition.

Other RAI Services Company trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03993795.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing